Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amphetamine-induced hypersensitivity in guinea pigs.

W J Weiner, C G Goetz, P A Nausieda

    Neurology
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

    Movement disorders : official journal of the Movement Disorder Society·2017
    Same author

    Revue neurologique·2017
    Same author

    Charcot, hysteria, and simulated disorders.

    Handbook of clinical neurology·2016
    Same author

    Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

    European journal of neurology·2014
    Same author

    Continuous in-home monitoring of essential tremor.

    Parkinsonism & related disorders·2013
    Same author

    Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

    European journal of neurology·2013
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Chronic d-amphetamine exposure in guinea pigs leads to hypersensitivity, not tolerance. This suggests underlying changes in the dopamine system, with implications for treating related clinical conditions.

    Area of Science:

    • Neuropharmacology
    • Behavioral Neuroscience

    Background:

    • Chronic drug administration can lead to tolerance or sensitization.
    • Amphetamine is a psychostimulant that affects the dopaminergic system.

    Purpose of the Study:

    • To investigate the long-term behavioral effects of chronic d-amphetamine administration in young guinea pigs.
    • To explore the underlying mechanisms of amphetamine-induced hypersensitivity.

    Main Methods:

    • Young guinea pigs received daily d-amphetamine for 6 months.
    • Brain amphetamine levels were compared between acute and chronic treatment groups.
    • Responsiveness to another dopaminergic agonist was assessed in pretreated animals.

    Main Results:

    • Chronic d-amphetamine exposure resulted in behavioral hypersensitivity and stereotyped behavior with decreased latency.

    Related Experiment Videos

  • No significant differences in brain amphetamine levels or drug distribution were observed between acute and chronic treatment.
  • Chronically treated guinea pigs showed hypersensitivity to a distinct dopaminergic agonist.

    • Conclusions:

    • Chronic d-amphetamine administration induces dopaminergic hypersensitivity in guinea pigs.
    • Altered drug metabolism does not explain the observed hypersensitivity.
    • Findings have implications for managing conditions involving chronic agonist-induced hypersensitivity.